Compare CLLS & PSFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CLLS | PSFE |
|---|---|---|
| Founded | 1999 | 1996 |
| Country | France | United Kingdom |
| Employees | N/A | 3300 |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 374.2M | 374.1M |
| IPO Year | 2014 | N/A |
| Metric | CLLS | PSFE |
|---|---|---|
| Price | $3.80 | $7.44 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 5 |
| Target Price | $8.50 | ★ $10.40 |
| AVG Volume (30 Days) | 35.0K | ★ 510.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $32.58 | $1.95 |
| Revenue Next Year | $20.68 | $6.21 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.10 | $5.95 |
| 52 Week High | $5.48 | $18.15 |
| Indicator | CLLS | PSFE |
|---|---|---|
| Relative Strength Index (RSI) | 45.66 | 59.66 |
| Support Level | $3.41 | $6.58 |
| Resistance Level | $4.46 | $8.65 |
| Average True Range (ATR) | 0.17 | 0.43 |
| MACD | 0.01 | 0.16 |
| Stochastic Oscillator | 40.00 | 79.68 |
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
Paysafe Ltd is an integrated payments platform. Its core purpose is to enable businesses and consumers to connect and transact seamlessly through capabilities in payment processing, digital wallet, and online cash solutions. The company provides payment solutions through three primary lines of business: Integrated Processing, Digital Wallet and eCash Solutions. It derives a majority of revenue from the USA followed by Germany, the UK, and all other countries.